AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Role of Harm Reduction in Treatment of Xylazine Use Disorder
The diagnosis of xylazine use disorder is certainly not in the DSM-5, it's not out there yet. So no, we're not typically managing patients for a prolonged period of time at the current time. We'd like to take some questions from the audience. Does anybody have any questions about this topic?